Old North State Wealth Management’s GSK GSK Stock Holding History

Old North State Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,689	Closed	-$204K	–	114
2026 Q1	$204K	Sell	3,689 -12,558	-77%	-$681K	0.09%	111
2025 Q4	$797K	Buy	16,247 +8	+0%	+$373	0.37%	54
2025 Q3	$701K	Buy	16,239 +1,470	+10%	+$57.4K	0.33%	62
2025 Q2	$568K	Buy	14,769 +423	+3%	+$16.2K	0.3%	66
2025 Q1	$556K	Buy	14,346 +4,281	+43%	+$157K	0.31%	60
2024 Q4	$341K	Buy	10,065 +4,685	+87%	+$169K	0.19%	80
2024 Q3	$220K	Buy	+5,380	New	+$220K	0.12%	105
2022 Q2	–	Sell	-67,969	Closed	-$3.7M	–	58
2022 Q1	$3.7M	Sell	67,969 -321	-0.5%	-$17.4K	3.7%	9
2021 Q4	$3.77M	Buy	+68,290	New	+$3.55M	3.8%	9

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Old North State Wealth Management's GSK Position: Q2 2026 in Review

Old North State Wealth Management sold out of GSK (GSK) in Q2 2026, closing a stake of 3,689 shares — an estimated $204K sold.

Old North State Wealth Management first reported a position in GSK in Q4 2021 and held it in 9 quarters. The position peaked at $3.77M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Old North State Wealth Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Old North State Wealth Management sold 3,689 GSK shares in Q2 2026, an estimated $204K.
Old North State Wealth Management first reported a position in GSK in Q4 2021 and held it in 9 quarters.
Old North State Wealth Management's GSK position peaked at $3.77M in Q4 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Old North State Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.